20 Common Diseases Updated ((link)): Sop For Diagnosis Of Top

This guide provides a standardized framework for the clinical diagnosis of the most frequently encountered conditions in primary and urgent care. These protocols are updated to reflect current evidence-based guidelines (2024-2025). 1. Essential Diagnostic Framework

Evaluated via fasting or non-fasting lipid profile based on cardiovascular risk scoring. Hypercholesterolemia: Total Cholesterol Hypertriglyceridemia: Fasting Triglycerides

Clinical symptoms accompanied by positive urinalysis findings and confirmatory culture. sop for diagnosis of top 20 common diseases updated

Standard Operating Procedures (SOP) for the Diagnosis of 20 Common Diseases

Referral for a Stress Test or CT Coronary Angiogram if symptoms are stable but persistent. 4. Metabolic & Endocrine Conditions 8. Diabetes Mellitus (Type 2) This guide provides a standardized framework for the

This Standard Operating Procedure (SOP) outlines the 2026 updated diagnostic protocols for the most common diseases seen in global primary and acute care 1. Scope and Objective

Disease 17: Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) sop for diagnosis of top 20 common diseases updated

| Rank | Disease/Condition | Category | Key 2025-2026 Update | | :--- | :--- | :--- | :--- | | 1 | Upper Respiratory Tract Infection (URTI) | Acute Infectious | New guidelines on pathogen-specific testing in children. | | 2 | Essential Hypertension | Cardiovascular | AHA/ACC updates reaffirm 130/80 mmHg threshold for Stage 1 HTN. | | 3 | Type 2 Diabetes Mellitus | Endocrine | ADA 2025 reinforces screening starting at age 35. | | 4 | Musculoskeletal Pain (Back/Joint Pain) | Musculoskeletal | Increased focus on non-pharmacological and multimodal care. | | 5 | Depressive & Anxiety Disorders | Mental Health | Emphasis on routine screening in primary care with tools like PHQ-9. | | 6 | Chronic Obstructive Pulmonary Disease (COPD) | Respiratory | GOLD 2025 clarifies spirometry use and initial assessment. | | 7 | Asthma | Respiratory | GINA 2025 shifts focus from "airflow limitation" to "airflow variability". | | 8 | Osteoarthritis | Musculoskeletal | Updated guidelines on pain management and conservative therapy. | | 9 | Acute Otitis Media (AOM) | Ear, Nose, Throat | New diagnostic criteria to differentiate from Otitis Media with Effusion (OME). | | 10 | Pneumonia | Respiratory | Updated community-acquired pneumonia (CAP) risk stratification tools. | | 11 | Urinary Tract Infection (UTI) | Infectious Disease | EAU 2025 introduces a new classification system. | | 12 | Gastroesophageal Reflux Disease (GERD) | Gastrointestinal | Rome IV algorithms refined for symptom-based diagnosis. | | 13 | Allergic Rhinitis | Immunological | Emphasis on distinguishing from non-allergic rhinitis. | | 14 | Coronary Artery Disease (CAD) | Cardiovascular | New risk calculators (e.g., PREVENT) for primary prevention. | | 15 | Dermatitis (Eczema/Contact Dermatitis) | Dermatological | Updated clinical criteria for atopic dermatitis. | | 16 | Anemia | Hematological | Routine screening for iron deficiency in at-risk populations. | | 17 | Irritable Bowel Syndrome (IBS) | Gastrointestinal | Continued use of Rome IV positive diagnostic criteria, not just exclusion. | | 18 | Migraine/Tension Headache | Neurological | Updated diagnostic criteria for various headache disorders. | | 19 | Conjunctivitis (Viral/Bacterial) | Ophthalmological | Differentiating features to avoid unnecessary antibiotic use. | | 20 | Sexually Transmitted Infections (e.g., Chlamydia) | Infectious Disease | Updated screening guidelines for asymptomatic at-risk individuals. |

Chest X-ray (PA and Lateral views) showing lobar consolidation, interstitial infiltrates, or cavitation. Complete Blood Count (CBC) showing leukocytosis ( ) or leukopenia ( ) with a left shift.

: Categorize patients (e.g., infectious vs. non-communicable) and implement immediate isolation if needed. Laboratory Investigation